Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care.
作者信息
Wathen C Nadine, Feig Denice S, Feightner John W, Abramson Beth L, Cheung Angela M
机构信息
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont.
出版信息
CMAJ. 2004 May 11;170(10):1535-7. doi: 10.1503/cmaj.1030756.
Abstract
摘要
相似文献
1
Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care.
CMAJ. 2004 May 11;170(10):1535-7. doi: 10.1503/cmaj.1030756.
2
Summaries for patients. Menopausal hormone therapy to prevent chronic conditions: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2013 Jan 1;158(1):I-34. doi: 10.7326/0003-4819-158-1-201301010-00554.
3
Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2013 Jan 1;158(1):47-54. doi: 10.7326/0003-4819-158-1-201301010-00553.
4
Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.
Am J Nurs. 2003 Jun;103(6):83-91.
5
Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
Ann Intern Med. 2005 May 17;142(10):855-60.
6
Postmenopausal hormone replacement therapy for the primary prevention of chronic condition. Recommendations and rationale. U.S. Preventive Services Task Force.
Am Fam Physician. 2003 Jan 15;67(2):358-64.
7
Postmenopausal hormone replacement therapy: scientific review.
JAMA. 2002 Aug 21;288(7):872-81. doi: 10.1001/jama.288.7.872.
8
Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations.
Ann Intern Med. 2012 Jul 17;157(2):104-13. doi: 10.7326/0003-4819-157-2-201207170-00466.
9
Summaries for patients. Hormone therapy to prevent chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
Ann Intern Med. 2005 May 17;142(10):I59. doi: 10.7326/0003-4819-142-10-200505170-00004.
10
Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale.
Ann Intern Med. 2002 Nov 19;137(10):834-9. doi: 10.7326/0003-4819-137-10-200211190-00013.
引用本文的文献
1
Hormone replacement and strength training positively influence balance during gait in post-menopausal females: a pilot study.
J Sports Sci Med. 2005 Dec 1;4(4):372-81. eCollection 2005 Dec.
2
Caloric restriction versus drug therapy to delay the onset of aging diseases and extend life.
Age (Dordr). 2005 Mar;27(1):39-48. doi: 10.1007/s11357-005-3284-4. Epub 2005 May 2.
3
Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy.
J Gen Intern Med. 2010 Sep;25(9):914-9. doi: 10.1007/s11606-010-1360-7. Epub 2010 Apr 28.
4
Complete health checkup for adults: Update on the Preventive Care Checklist Form.
Can Fam Physician. 2008 Jan;54(1):84-8.
5
Perimenopausal and Postmenopausal Health.
BMC Womens Health. 2004 Aug 25;4 Suppl 1(Suppl 1):S23. doi: 10.1186/1472-6874-4-S1-S23.
6
Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.
CMAJ. 2004 May 25;170(11):1665-7. doi: 10.1503/cmaj.1030757.
本文引用的文献
1
Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.
CMAJ. 2004 May 25;170(11):1665-7. doi: 10.1503/cmaj.1030757.
2
Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease. Recommendation statement from the Canadian Task Force on Preventive Health Care.
CMAJ. 2004 Apr 27;170(9):1388-9. doi: 10.1503/cmaj.1030755.
3
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
JAMA. 2004 Apr 14;291(14):1701-12. doi: 10.1001/jama.291.14.1701.
4
Breast cancer and hormone-replacement therapy in the Million Women Study.
Lancet. 2003 Aug 9;362(9382):419-27. doi: 10.1016/s0140-6736(03)14065-2.
5
Estrogen plus progestin and the risk of coronary heart disease.
N Engl J Med. 2003 Aug 7;349(6):523-34. doi: 10.1056/NEJMoa030808.
6
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
JAMA. 2003 May 28;289(20):2663-72. doi: 10.1001/jama.289.20.2663.
7
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
JAMA. 2003 May 28;289(20):2651-62. doi: 10.1001/jama.289.20.2651.
8
Effects of estrogen plus progestin on health-related quality of life.
N Engl J Med. 2003 May 8;348(19):1839-54. doi: 10.1056/NEJMoa030311. Epub 2003 Mar 17.
9
Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale.
Ann Intern Med. 2002 Nov 19;137(10):834-9. doi: 10.7326/0003-4819-137-10-200211190-00013.
10
Postmenopausal hormone replacement therapy: scientific review.
JAMA. 2002 Aug 21;288(7):872-81. doi: 10.1001/jama.288.7.872.
Zotero 插件